EUVIMEDEUVIMED entdecken
Crossref

Metabolomic signature of retinal ageing, polygenetic susceptibility, and major health outcomes

Riqian Liu, Shaopeng Yang, Xiaoying Zhong, Ziyu Zhu, Wenyong Huang, Wei Wang

British Journal of Ophthalmology · 2025

DOI: 10.1136/bjo-2024-325846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2025. Verfasst von Riqian Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdon…. Hauptthemen laut MEDLINE: Metabolomics, Aging, Retina, Genetic Predisposition to Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aims To identify the metabolic underpinnings of retinal aging and examine how it is related to mortality and morbidity of common diseases.

Methods

The retinal age gap has been established as essential aging indicator for mortality and systemic health. We applied neural network to train the retinal age gap among the participants in UK Biobank and used nuclear magnetic resonance (NMR) to profile plasma metabolites. The metabolomic signature of retinal ageing (MSRA) was identified using an elastic network model. Multivariable Cox regressions were used to assess associations between the signature with 12 serious health conditions. The participants in Guangzhou Diabetic Eye Study (GDES) cohort were analyzed for validation.

Results

This study included 110 722 participants (mean age 56.5±8.1 years at baseline, 53.8% female), and 28 plasma metabolites associated with retinal ageing were identified. The MSRA revealed significant correlations with each 12 serious health conditions beyond traditional risk factors and genetic predispositions. Each SD increase in MSRA was linked to a 24%–76% higher risk of mortality, cardiovascular diseases, dementia and diabetes mellitus. MSRA showed dose–response relationships with risks of these diseases, with seven showing non-linear and five showing linear increases. Validation in the GDES further established the relation between retinal ageing-related metabolites and increased risks of cardiovascular and chronic kidney diseases (all p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsAgingRetinaGenetic Predisposition to DiseaseRetinal DiseasesMetabolomeHumansFemaleMaleMiddle AgedAgedRisk FactorsMagnetic Resonance SpectroscopyBiomarkers

Stichwörter der Autor:innen

EpidemiologyGeneticsImagingPublic healthRetina

Substanzen

Biomarkers

Autor:innen und Institutionen

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Study Center for Ocular Diseases, Sun Yat-Sen Un…
  • Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, R., Yang, S., Zhong, X., Zhu, Z., Huang, W., & Wang, W. (2025). Metabolomic signature of retinal ageing, polygenetic susceptibility, and major health outcomes. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2024-325846

Vancouver

Liu R, Yang S, Zhong X, Zhu Z, Huang W, Wang W. Metabolomic signature of retinal ageing, polygenetic susceptibility, and major health outcomes. British Journal of Ophthalmology. 2025. doi:10.1136/bjo-2024-325846

BibTeX
@article{Liu2025,
  author = {Liu, Riqian and Yang, Shaopeng and Zhong, Xiaoying and Zhu, Ziyu and Huang, Wenyong and Wang, Wei},
  title = {Metabolomic signature of retinal ageing, polygenetic susceptibility, and major health outcomes},
  journal = {British Journal of Ophthalmology},
  year = {2025},
  doi = {10.1136/bjo-2024-325846}
}
Kostenlos starten →